Moreover, the GSTM1/GSTT1 null genotype has been reported to confer a slight increase in risk [OR: 1.33 (95% CI: 1.10–1.61)] of lung cancer in a small-scale meta-analysis [11]. Here, GSTM1 is linked to lung carcinoma.